1 – 14 of 14
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
COMBAT-MS : A Population-Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
2024) In Annals of Neurology(
- Contribution to journal › Article
- 2023
-
Mark
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
2023) In Journal of Neurology, Neurosurgery and Psychiatry(
- Contribution to journal › Article
-
Mark
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
(
- Contribution to journal › Article
- 2022
-
Mark
COVID-19 clinical outcomes and DMT of MS patients and population-based controls
(
- Contribution to journal › Article
- 2020
-
Mark
Cigarette smoking patterns preceding primary Sjögren’s syndrome
(
- Contribution to journal › Article
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
Infection Risks among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
(
- Contribution to journal › Article
- 2019
-
Mark
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
(
- Contribution to journal › Article
- 2017
-
Mark
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
(
- Contribution to journal › Article
- 2013
-
Mark
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
(
- Contribution to journal › Article
- 2011
-
Mark
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
(
- Contribution to journal › Article
- 2009
-
Mark
Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions
(
- Contribution to journal › Article
- 2008
-
Mark
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
(
- Contribution to journal › Article
- 2006
-
Mark
Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes
(
- Contribution to journal › Article